X., Warnick, J.E.,Maleque, M.A.,Kauffman,...
Transcript of X., Warnick, J.E.,Maleque, M.A.,Kauffman,...
AUTHOR INDEX FOR VOLUME 19
529
A
Aarbakke, Jarle, and Ueland, Per M. Interaction of s-Adenosylho-
mocysteine with Isolated Rat Hepatocytes, 463
Albuquerque, E. X., Warnick, J. E., Maleque, M. A., Kauffman,F. C., Tamburini, R., Nimit, Y., and Daly, J. W. The Pharma-
cology of Pumiiotoxin-B. I. Interaction with Calcium Sites in the
Sarcoplasmic Reticulum of Skeletal Muscle, 411
Alonso, Angel. See Kuhn and Heinrich, 103
Appu Rao, A. G., and Cairn, John R. A Comparative Study of the
Interaction of Chiorpromazine, Trifluoperazine, and Promethazine
with Mouse Brain Tubulin, 295
Arduengo, A. J. See Kilbourn, Park, and Katzenellenbogen, 388
Ashley, Patricia L., and Griffin, Brenda Walker. Involvement of
Radical Species in the Oxidation of Aminopyrine and 4-Aminoan-
tipyrine by Cumene Hydroperoxide in Rat Liver Microsomes, 146
B
Bachur, Nicholas R. See Pan and Pedersen, 184
Baker, Peter F. See Honerjdger and Reiter, 68
Baizarini, J. See De Clercq, Torrence, Mertes, Schmidt, Shugar,
Barr, Jones, Verhelst, and Walker, 321
Bannon, Michael J., Michaud, Richard L., and Roth, Robert H.Mesocortical Dopamine Neurons: Lack of Autoreceptors Modulat-
ing Dopamine Synthesis, 270
Barber, Roger, and Butcher, Reginald W. The Quantitative Rela-
tionship between Intracellular Concentration and Egress of Cyclic
AMP from Cultured Cells, 38
Barr, P. J. See De Clercq, Baizarini, Torrence, Mertes, Schmidt,
Shugar, Jones, Verhelst, and Walker, 321
Beaulleu, Denise. See Rosenblatt, Whitehead, Vuchich, Pottier, and
Matiaszuk, 87
Belvedere, G. See Gozukara, Robinson, Deutsch, Coon, Guengerich,
and Gelboin, 153
Bergman, Mark 0. See Olsen, Van Ness, Lummis, Watkins, Napias,
and Greenlee, 217
Bertino, Joseph R. See Scanlon, Cashmore, Moroson, and Dreyer,
481
Billiau, Alfons. See De Clercq, Heremans, Descamps, Verhelst, and
De Ley, 122
Bourne, Henry R. See Salomon, 109
Brennan, M. J. W., Cantrill, R. C., Oldfield, M., and Krogsgaard-
Larsen, P. Inhibition of ‘y-Aminobutyric Acid Agonist Drugs:
Pharmacology of the ‘y-Aminobutyric Acid Receptor, 27
Brown, Kenneth B. See Pringle and Miller, 49
Burgisser, Ernst, Hancock, Arthur A., Lefkowitz, Robert J., and
De Lean, Andre. Anomalous Equilibrium Binding Properties of
High-Affinity Racemic Radioligands, 205
Burgisser, Ernst, Lefkowitz, Robert J., and De Lean, Andre.
Alternative Explanation for the Apparent “Two-Step” Binding
Kinetics of High-Affinity Racemic Antagonist Radioligands, 509
Butcher, Reginald W. See Barber, 38
Byrne, John R. See Milne, 276
C
Camerman, Arthur. See Camerman, 517
Camerman, Norman, and Camerman, Arthur. On the Stereochem-
istry of Dopaminergic Ergoline Derivatives, 517
Cann, John R. See Appu Rao, 295
Cantor, Elinor H., Greenberg, Louise H., and Weiss, Benjamin.
Effect of Long-Term Changes in Sympathetic Nervous Activity on
the Beta-Adrenergic Receptor-Adenylate Cyclase Complex of Rat
Pineal Gland, 21
Cantrill, R. C. See Brennan, Oldfield, and Krogsgaard.Larsen, 27
Cascales, Maria. See Cerddn and Santos-Ruiz, 451
Cashmore, Arlene R. See Scanlon, Moroson, Dreyer, and Bertino,
481
Catterall, William A., and Risk, Martin. Toxin T.,, from Ptychod.
iscus brevis (Formerly Gymnodinium breve) Enhances Activation
of Voltage-Sensitive Sodium Channels by Veratridine, 345
Catterall, William A. See Tamkun, 78
Cerd#{225}n, Sebastian, Cascales, Maria, and Santos-Ruiz, Angel.
Effect of Thioacetamide on the Pentose Phosphate Pathway and
Other NADP-Linked Enzymes of Rat Liver Cytosol: Chronology
of the Perturbations and Metabolic Significance, 451
Chang, Jaw Kang. See Vvu, Lee, Ling, Loh, and Yang, 302
Chin, J. H., and Goldstein, D. B. Membrane-Disordering Action of
Ethanol: Variation with Membrane Cholesterol Content and
Depth of the Spin Label Probe, 425
Christopherson, Rose. See Wartell, Watkins, and Rannels, 520
Cimino, Mauro. See Prozialeck and Weiss, 264
Cole, Susan P. C., Zelt, David T., and Marks, Gerald S. Comparison
of the Effects of Griseofulvin and 3,5-Diethoxycarbonyl-1,4-dihy-
dro-2,4,6-trimethylpyridine on Ferrochelatase Activity in Chick
Embryo Liver, 477
Conn, P. Michael. See Marian and Cooper, 399
Conney, A. H. See Nordqvist, Thakker, Vyas, Yagi, Levin, Ryan,
Thomas, and Jerina, 168
Coon, J. J. See Gozukara, Belvedere, Robinson, Deutsch, Guengerich,
and Gelboin, 153
Cooper, Ralph L. See Marian and Conn, 399
Cox, David. See Kaslow, Groppi, and Bourne, 406
Cusi, D., and Garay, R. P. The Effect ofTieniic Acid on Na� and K�
Transport in Human Red Cells, 438
D
Daly, J. W. See Albuquerque, Warnick, Maleque, Kauffman, Tam.
burini, and Nimit, 411
De Clercq, E., Baizarini, J., Torrence, P. F., Mertes, M. P.,
Schmidt, C. L., Shugar, D., Barr, P. J., Jones, A. S., Verhelst,
G., and Walker, R. T. Thymidylate Synthetase as Target Enzyme
for the Inhibitory Activity of 5-Substituted 2’-Deoxyuridines on
Mouse Leukemia L1210 Cell Growth, 321
De Clercq, Erik, Heremans, Hubertine, Descamps, Johan, Ver-
helst, Gabriel, De Ley, Marc, and Billiau, Alfons. Effects of
E-5-(2-Bromovinyl)-2’-Deoxyuridine and Other Selective Anti-
Herpes Compounds on the Induction of Retrovirus Particles in
Mouse BALB/3T3 Cells, 122
De Lean, Andre. See Burgisser, Hancock, and Lefkowitz, 205
De Lean, Andre. See B#{252}rgisser and Lefkowitz, 509
De Ley, Marc. See De Clercq, Heremans, Descamps, Verheist, and
Billiau, 122
Descamps, Johan. See De Clercq, Herermans, Verheist, De Lev, and
Billiau, 122
Deutsch, J. See Gozukara, Belvedere, Robinson, Coon, Guengerich,
and Gelboin, 153
Dickinson, K., Richardson, A., and Nahorski, S. R. Homogeneity
of Beta�-Athenoceptors on Rat Erythrocytes and Reticulocytes: A
Comparison with Heterogeneous Rat Lung Beta-Adrenoceptors,
194
Dreyer, Robert N. See Scanlon, Cashmore, Moroson, and Bertino,
481
Duffell, Michael W., Graham, J. Michael, and Ziegler, D. M.
Changes in Dimethylaniine N-Oxidase Activity of Mouse Liver
and Kidney Induced by Steroid Sex Hormones, 134
Dunn, Deborah A. See Sufrmn and Marshall, 307
530 AUTHOR INDEX
E
Ehlert, Frederick J., Roeske, Wiffiam R., and Yamamura, Henry
I. Mathematical Analysis of the Kinetics of Competitive Inhibition
in Neurotransmitter Receptor Binding Assays, 367
Eisen, Judith S. See Lingle and Marder, 349
El-Fakahany, Esam, and Richelson, Elliott. Effects of Lanthanides
on Muscarinic Acetylcholine Receptor Function, 282
Erickson, Leonard C. See Ramonas, Kiesse, Kohn, and Zaharko,
331
F
Firnau, Gunter, Sood, Sudesh, Pantel, Richard, and Garnett,Stephen. Phenol Ionization in Dopa Determines the Site of Meth-
ylation by Catechol-O-Methyltransferase, 130
Forte, Anthony J. See Nelson, Vaishnav, Mitchell, Gillette, and
Hinson, 140
Frazer, Alan. See Moyer, Greenberg, and Weiss, 187
Freer, Richard J. See Rubin and Sink, 31
Friedman, Stanley. The Inhibition of DNA(Cytosine-5)Methylases
by 5-Azacytidine: The Effect of Azacytosine-Contnining DNA, 314
Frigon, Ronald P., O’Connor, Daniel T., and Levine, Gail L
Human Dopamine-fl-Hydroxylase: Comparison of the Enzyme
from Plasma, Adrenal Medulla, and Pheochromocytoma by Ha-
dioimmunoassay, 444
G
Galivan, John. See Whiteley and Nimec, 505
Galla, H. J., and Trudell, J. R. Perturbation of Peptide-Induced
Lateral Phase Separations in Phosphatidic Acid Bilayers by the
Inhalation Anesthetic Methoxyflurane, 432
Garay, R. P. See Cusi, 438
Garnett, Stephen. See Firnau, Sood, and Pantel, 130
Gelboin, H. V. See Gozukara, Belvedere, Robinson, Coon, and Guen-
gerich, 153
Gillette, James R. See Nelson, Forte, Vaishnav, Mitchell, and Hin-son, 140
Glazer, Robert I., and Hartman, Kathleen D. Analysis of the Effect
of 5-Fluorouracil on the Synthesis and Translation of Polysomal
Poly(A)RNA from Ehrlich Ascites Cells, 117
Gnegy, M., and Treismann, G. Effect of Calmodulin on Dopamine-
Sensitive Adenylate Cyclase Activity in Rat Striatal Membranes,
256
Goldstein, D. B. See Chin, 425
Gozukara, E. M., Belvedere, G., Robinson, R. C., Deutsch, J.,Coon, M. J., Guengerich, F. P., and Gelboin, H. V. The Effect
of Opoxide Hydratase on Benzo[alpyrene Diol Epoxide Hydrolysis
and Binding to DNA and Mixed-Function Oxidase Proteins, 153
Graham, J. Michael. See Duffel and Ziegler, 134
Greenberg, Louise H. See Cantor and Weiss, 21
Greenberg, Louise H. See Moyer, Frazer, and Weiss, 187
Greenlee, Donald V. See Olsen, Bergman, Van Ness, Lummi.s, Wat.
kins, and Napias, 217
Griffin, Brenda Walker. See Ashley, 146
Groppi, Vincent E. See Kaslow, Cox, and Bourne, 406
Guengerich, F. P. See Gozukara, Belvedere, Robinson, Deutsch,
Coon, and Gelboin, 153
H
Hamrell, Michael R., Laszlo, John, and Sedwick, W. David.
Transient Induction of Phenotypic Resistance in Human Lympho-
blastoid Cells following Sequential Use of Two Antifolates, 491
Hancock, Arthur A. See B#{252}rgisser, Lefkowitz, and De Lean, 205
Hanson, Mats. Effects of Mitosis Inhibitors on Respiration and Fast
Axonal Transport in Frog Sciatic Nerves, 291
Hartman, Kathleen D. See Glazer, 117
Heidenreich, Kim A. See Zahniser and Molinoff, 372
Heinrich, Peter C. See Kuhn and Alonso, 103
Heremans, Hubertine. See De Clercq, Descamps, Verheist, De Ley,and Billiau, 122
Hill, S. J., and Young, J. M. Characterization of [3H]Mepyramine
Binding to the Longitudinal Muscle of Guinea Pig Small Intestine,
379
Hinson, Jack A. See Nelson, Forte, Vaishnav, Mitchell, and Gillette,
140
Honerj#{225}ger, Peter, Reiter, Melchior, and Baker, Peter F. Effect
of the Cardioactive Drug AR-L 57 on Free Intracellular Calcium
and Ouabain-Insensitive Ion Fluxes in the Squid Giant Axon, 68
I
Iba, Michael M. See Nerland and Mannering, 162
Insel, Paul A. See Shattil, McDonough, and Turnbull, 179
J
Jacoby, Richard. See Levin and Wein, 525
Jerina, D. M. See Nordqvist, Thakker, Vyas, Yagi, Levin, Ryan,
Thomas, and Conney, 168
Ji, Sungchul, Lemasters, John J., and Thurman, Ronald G. A
Fluorometric Method To Measure Sublobular Rates of Mixed-
Function Oxidation in the Hemoglobin-Free Perfused Rat Liver,
513
Jones, A. S. See De Clercq, Balzarini, Torrence, Mertes, Schmidt,
Shugar, Barr, Verhelst, and Walker, 321
K
Kaslow, Harvey R., Cox, David, Groppi, Vincent E., and Bourne,
Henry R. An Mr 52,000 Peptide Can Mediate Effects of Cholera
Toxin on Adenylate Cylase in Intact Cells, 406
Katzenellenbogen, John A. See Kilbourn, Arduengo, and Park, 388
Kauffman, F. C. See Albuquerque, Warnick, Maleque, Tamburini,
Nimit, and Daly, 411
Kilbourn, Michael R., Arduengo, A. J., Park, Joon T., and Katz-
enellenbogen, John A. Conformational Analysis of Nonsteroidal
Estrogens: The Effect of Conformer Populations on the Binding
Affinity of meso- and dl-Hexestrol to the Estrogen Receptor, 388
Kitano, Takafuini. See Vaught and Takemori, 236
Klesse, Wolfgang. See Ramonas, Erickson, Kohn, and Zaharko, 331
Kohn, Kurt W. See Ramonas, Erickson, Klesse, and Zaharko, 331
Konopa, Jerry. See Woynarowski, 97
Krogsgaard-Larsen, P. See Brennan, Cantrill, and Oldfield, 27
KUhn, Barbara, Alonso, Angel, and Heinrich, Peter C. The Effectof D-Galactosamine and Actinomycin D on Polysomes and Mes-
senger RNA Levels in Rat Liver, 103
L
Laszlo, John. See Hamrell and Sedwick, 491
Law, P. Y., Ostwald, T. J., Way, E. L, and Loh, H. H. Interaction
of Diazosulfaniic Acid and the Opiate Receptor: Inhibition of
Specific Binding to Synaptic Membranes and Labeling of a Mem-
brane Lipid Stereospecifically Protected by Opiods, 355
LeDuc, Louise E., Wyche, Angela A., Sprecher, Howard, San-
karappe, S. K., and Needleman, Philip. Analogues of Arachi-
donic Acid Used To Evaluate Structural Determinants of Prosta-
glandin Receptor and Enzyme Specificities, 242
Lee, Nancy M. See Wu, Ling, Chang, Loh, and Yang, 302
Lefkowitz, Robert J. See B#{252}rgisser and De Lean, 509
Lefl(owitz, Robert J. See Bzirgisser, Hancock, and De Lean, 205
Lemasters, John J. See Ji and Thurman, 513
Levin, Robert M., Jacoby, Richard, and Wein, Alan J. Effect of
Adenosine Triphosphate on Contractility and Adenosine Triphos-
phatase Activity of the Rabbit Urinary Bladder, 525Levin, W. See Nordqvist, Thakker, Vyas, Yagi, Ryan, Thomas, Con-
ney, and Jerina, 168
Levine, Gail L. See Frigon and O’Connor, 444
lAng, Nicholas. See Wu, Lee, C/tang, Loh, and Yang, 302
Lingle, Chris, Eisen, Judith S., and Marder, Eve. Block of Gluts-
matergic Excitatory Synaptic Channels by Chlorisondamine, 349
Loh, H. H. See Law, Ostwald, and Way, 355
AUTHOR INDEX 531
Loh, Horace H. See Wu, Lee, Ling, Chang, and Yang, 302
Lopez, J. Raphael. See Wastek and Richelson, 15
Lummis, Sarah C. See Olsen, Bergman, Van Ness, Watkins, Napias,
and Greenlee, 217
M
Macfarlane, Donald E. The Effects of Methyl Mercury on Platelets.
Induction of Aggregation and Release via Activation of the Pros-
taglandin Synthesis Pathway, 470
Maleque, M. A. See Albuquerque, Warnick, Kauffman, Tamburini,
Nimit, and Daly, 411
Mannering, Gilbert J. See Nerland and Iba, 162
Marder, Eve. See Lingle and Eisen, 349
Marian, Jan, Cooper, Ralph L., and Conn, P. Michael. Regulation
of the Rat Pituitary Gonadotropin-Releasing Hormone Receptor,
399
Marks, Gerald S. See Cole and Zelt, 477
Marshall, Garland R. See Sufrmn and Dunn, 307
Matiaszuk, N. Vera. See Rosenblatt, Whitehead, Vuchich, Pottier,
and Beaulieu, 87
Maynert, E. W. See Moon and Pai, 44
McDonough, Margaret. See Shattil, Turnbull, and Insel, 179
McMahon, Kathryn K. See Schimmel and Serio, 248
Mertes, M. P. See De Clercq, Balzarini, Torrence, Schmidt, Shugar,
Barr, Jones, Verhelst, and Walker, 321
Michaud, Richard L. See Bannon and Roth, 270
Miller, Keith W. See Pringle and Brown, 49
Milne, Richard J., and Byrne, John R. Effects of Hexamethonium
and Decamethonium on End-Plate Current Parameters, 276
Minton, Allen P. The Bivalent Ligand Hypothesis: A Quantitative
Model for Hormone Action, 1
Mitchell, Jerry R. See Nelson, Forte, Vaishnav, Gillette, and Hinson,
140
Molinoff, Perry B. See Zahniser and Heidenreich, 372
Moon, B. H., Pai, V. S., and Maynert, E. W. Ring Stacking in
Solutions of Norepinephrine and the 4:1 Norepinephrine .ATP
Complex, 44
Moroson, Barbara A. See Scanlon, Cashmore, Dreyer, and Bertino,
481
Moyer, John A., Greenberg, Louise H., Frazer, Alan, and Weiss,
Benjamin. Subsensitivity of the Beta-Adrenergic Receptor-
Linked Adenylate Cyclase System of Rat Pineal Gland following
Repeated Treatment with Desmethylimipramine and Nialamide,
187
N
Nahorski, S. R. See Dickinson and Ricardson, 194
Napias, Christian. See Olsen, Bergman, Van Ness, Lummis, Wat-
kins, and Greenlee, 217
Needleman, Philip. See LeDuc, Wyche, Sprecher, and Sankarappe,
242
Nelson, Sidney D., Forte, Anthony J., Vaishnav, Yashesh, Mitch-
ell, Jerry H., Gillette, James R., and Hinson, Jack A. TheFormation of Arylating and Alkylating Metabolites of Phenacetin
in Hamsters and Hamster Liver Microsomes, 140
Nerland, Donald E., Iba, Michael M., and Mannering, Gilbert J.
Use of Linoleic Acid Hydroperoxide in the Determination of Ab-
solute Spectra of Membrane-Bound Cytochrome P-450, 162
Nimec, Zenia. See Whiteley and Galivan, 505
Nimit, Y. See Albuquerque, Warnick, Maleque, Kauffman, Tambu-
rini, and Daly, 411
Nordqvist, M., Thakker, D. R., Vyas, K. P., Yagi, H., Lavin, W.,Ryan, D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M.
Metabolism of Chrysene and Phenanthrene to Bay-Region Diol
Epoxides by Rat Liver Enzymes, 168
0
O’Connor, Daniel T. See Frigon and Levine, 444Ohuchi, Kazuo. See Yamazaki, Sasaki, and Sakai, 456
Oldfield, M. See Brennan, Cantrill, and Krogsgaard-Larsen, 27
Olsen, Richard W., Bergman, Mark 0., Van Ness, Paul C., Lum-
mis, Sarah C., Watkins, Andrew E., Napias, Christian, andGreenlee, Donald V. y-Aminobutyric Acid Receptor Binding in
Mammalian Brain: Heterogeneity of Binding Sites, 217
Ostwald, T. J. See Law, Way, and Loh, 355
P
Pal, V. S. See Moon and Maynert, 44
Pan, Su-Shu, Pedersen, Leslie, and Bachur, Nicholas R. Compar-
ative Flavoprotein Catalysis of Anthracycline Antibiotic: Reduc-
tive Cleavage and Oxygen Consumption, 184
Pantel, Richard. See Firnau, Sood, and Garnett, 130
Park, Joon T. See Kilbourn, Arudengo, and Katzenellenbogen, 388Pedersen, Leslie. See Pan and Bachur, 184
Pottier, A. See Rosenblatt, Whitehead, Vuchich, Matiaszuk, and
Beaulieu, 87
Pringle, Michael J., Brown, Kenneth B., and Miller, Keith W.
Can the Lipid Theories of Anesthesia Account for the Cutoff in
Anesthetic Potency in Homologous Series of Alcohols?, 49
Prozialeck, Walter C., Cimino, Mauro, and Weiss, Benjamin.
Photoaffinity Labeling of Calmodulin by Phenothiazine Antipsy-
chotics, 264
R
Ramonas, Lori M., Erickson, Leonard C., Kiesse, Wolfgang,
Kohn, Kurt W., and Zaharko, Daniel S. Differential Cytotox-
icity and DNA Cross-Linking Produced by Polymeric and Mono-
meric Activated Analogues of Cyclophosphamide in Mouse L1210
Leukemia Cells, 331
Rannels, D. Eugene. See Wartell, Christopherson, and Watkins, 520
Reiter, Melchior. See Honerjdger and Baker, 68Richardson, A. See Dickinson and Nahorski, 194
Richelson, Elliott. See El-Fakahany, 282
Richelson, Elliott. See Wastek and Lopez, 15
Risk, Martin. See Catterall, 345
Robinson, R. C. See Gozukara, Belvedere, Deutsch, Coon, Guenger-
ich, and Gelboin, 153
Roeske, William R. See Ehlert and Yamamura, 367
Rosenblatt, D. S., Whitehead, V. M., Vuchich, M.-J., Pottier, A.,
Matiaszuk, N. Vera, and Beaulieu, Denise. Inhibition of Meth-
otrexate Polyglutamate Accumulation in Cultured Human Cells,
87
Roth, Robert H. See Bannon and Michaud, 270
Rubin, Ronald P., Sink, Lynn E., and Freer, Richard J. On the
Relationship between Formylinethionyl-Leucyl-Phenylalanine
Stimulation of Arachidonyl Phosphatidylinositol Turnover and
Lysosomal Enzyme Secretion by Rabbit Neutrophils, 31
Ryan, D. E. See Nordqvist, Thakker, Vyas, Yagi, Thomas, Conney,
and Jerina, 168
S
Sakai, Kiyoshi. See Yamazaki, Ohuchi, and Sasaki, 456
Salomon, Michael R., and Bourne, Henry R Novel 549 Lymphoma
Variants with Aberrant Cyclic AMP Metabolism, 109
Sankarappe, S. K. See LeDuc, Wyche, Sprecher, and Needleman,
242
Santos-Ruiz, Angel. See Cerdcmn and Ca-scales, 451
Sasaki, Masaaki. See Yamazaki, Ohuchi, and Sakai, 456
Scanlon, Kevin J., Cashmore, Arlene R., Moroson, Barbara A.,
Dreyer, Robert N., and Bertino, Joseph R. Inhibition of Serine
Metabolism by Tetrahydrohomofolate in L1210 Mouse Leukemia
Cells, 481
Schimniel, Richard J., McMahon, Kathryn K., and Serb, Rosa!-
md. Interactions between Alpha-Adrenergic Agents, Prostaglan-
din E1, Nicotinic Acid, and Adenosine in Regulation of Lipolysis in
Hamster Epididymal Adipocytes, 248
Schmidt, C. L. See De Clercq, Balzarini, Torrence, Mertes, Shugar,
Barr, Jones, Verhelst, and Walker, 321
532 AUTHOR INDEX
The Subject Index for Volume 19 will appear in the November 1981 issue as part of a cumulative index for the year 1981.
Schuette, Barbara P. See Vistica, 92
Schwabe, Ulrich. See Trost, 228
Sedwick, W. David See Hamrell and Laszlo, 491
Serio, Rosalind. See Schimmel and McMahon, 248
Shattil, Sanford J., McDonough, Margaret, Turnbull, Judy, andInsel, Paul A. Characterization ofAlpha-Adrenergic Receptors in
Human Platelets Using [3H]Clonidine, 179
Shiah, Shii-Pying. See Stern, 56Shugar, D. See De Clercq, Balzarini, Torrence, Mertes, Schmidt,
Barr, Jones, Verhelst, and Walker, 321
Sink, Lynn E. See Rubin and Freer, 31
Sood, Suresh. See Firnau, Pantel, and Garnett, 130
Spears, C. Paul. Nucleophilic Selectivity Ratios of Model and Clinical
Alkylating Agents by 4-(4’-Nitrobenzyl)pyridine Competition, 496
Sprecher, Howard. See LeDuc, Wyche, Sankarappe, and Needle-
man, 242
Stern, S. Alexander, and Shiah, Shii-Pying. Solubiity of Inhalation
Anesthetics in Various Media: A New Correlation, 56
Sufrmn, Janice R., Dunn, Deborah A., and Marshall, Garland R.Stenc Mapping of the L-Methiomne Binding Site of ATP: L-
Methionine S-Adenosyltransferase, 307
T
Takemori, A. E. See Vaught and Kitano, 236
Tamburini, R. See Albuquerque, Warnick, Maleque, Kauffman,Nimit, and Daly, 411
Tamkun, Michael M., and Catterall, William A. Ion Flux Studies
of Voltage-Sensitive Sodium Channels in Synaptic Nerve-Ending
Particles, 78
Thakker, D. R. See Nordqvist, Vyas, Yogi, Levin, Ryan, Thomas,
Conney, and Jerina, 168
Thomas, P. E. See Nordqvist, Thakker, Vyas, Yogi, Ryan, Conney,
andJerina, 168
Thorgeirsson, Snorri S. See Wirthe, 337
Thurman, Ronald G. See Ji and Lemasters, 513
Torrence, P. F. See De Clercq, Balzarini, Mertes, Schmidt, Shugar,
Barr, Jones, Verhelst, and Walker, 321
Treismann, G. See Gnegy, 256
Trost, Thomas, and Schwabe, Ulrich. Adenosine Receptors in Fat
Cells: Identification by (-)-N6-[3H]Phenylisopropyladensoine
Binding, 228
Trudell, J. R. See Galla, 432Turnbull, Judy. See Shattil, McDonough, and Insel, 179
U
Ueland, Per M. See Aarbakke, 463
V
Vaishnav, Yashesh. See Nelson, Forte, Mitchell, Gillette, and Hin-
son, 140
Van Ness, Paul C. See Olsen, Bergman, Lummis, Watkins, Napias,
and Greenlee, 217
Vaught, Jeifry L, Kitano, TakafUmi, and Takemori, A. E. Inter-
actions of Leucine Enkephalin and Narcotics with Opioid Recep-
tom, 236
Verhelst, G. See De Clercq, Balzarini, Torrence, Mertes, Schmidt,Shugar, Barr, Jones, and Walker, 321
Verheist, Gabriel. See De Clercq, Heremans, Descamps, De Ley, and
Billiau, 122
Vistica, David T., and Sehuette, Barbara P. Carrier Mechanism
and Specificity Accounting for the Increase in Intracellular Mel-
phalan by the Basic Amino Acids, 92
Vuchich, M.-J. See Rosenblatt, Whitehead, Pottier, Matiaszuk, and
Beaulieu, 87
Vyas, K. P. See Nordqvist, Thakker, Yagi, Levin, Ryan, Thomas,
Conney, and Jerina, 168
W
Walker, R. T. See De Clercq, Balzarini, Torrence, Mertes, Schmidt,S/sugar, Barr, Jones, and Verhelst, 321
Warnick, J. E. See Albuquerque, Maleque, Kauffman, Tamburini,Nimit, and Daly, 411
Wartell, Sue A., Christopherson, Rose, Watkins, Clyde A., and
Rannels, D. Eugene. Inhibition of Synthesis of Lung Proteins by
Halothane, 520
Wastek, Gregory J., Lope; J. Raphael, and Richelson, Elliott.Demonstration of a Muscarmnic Receptor-Mediated Cyclic GMP-
Dependent Hyperpolarization of the Membrane Potential of
Mouse Neuroblastoma Cells Using [3H]Tetraphenylphosphonium,
15
Watkins, Andrew E. See Olsen, Bergman, Van Ness, Lummis, Na-
pias, and Greenlee, 217
Watkins, Clyde A. See Wartell, Christopherson, and Rannels, 520
Way, E. L. See Law, Ostwald, and Loh, 355
Wein, Alan J. See Levin and Jacoby, 525
Weiss, Benjamin. See Cantor and Greenberg, 21
Weiss, Benjamin. See Moyer, Greenberg, and Frazer, 187
Weiss, Benjamin. See Prozialeck and Cimino, 264
Whitehead, V. M. See Rosenblatt, Vuchich, Pottier, Matiaszuk, and
Beaulieu, 87
Whiteley, John M., Nimec, Zenia, and Gailvan, John. Treatment
of Reuber H35 Hepatoma Cells with Carrier-Bound Methotrexate,
505
Wirthe, Peter J., and Thorgeirsson, Snorri S. Mechanism of N-
Hydroxy-2-Acetylaminofluorene Mutagenicity in the Salmonella
Test System: Role of N-O Acyltransferase and Sulfotransferase
from Rat Liver, 337
Woynarowski, Jan M., and Konopa, Jerry. Inhibition of DNA
Biosynthesis in HeLa Cells by Cytotoxic and Antitumor Sesquiter-
pene Lactones, 97
Wu, Chuen-Shang C., Lee, Nancy M., Ling, Nicholas, Chang, Jaw
Kang, Loh, Horace H., and Yang, Jen Tsi. Conformation of
$-Endorphin Analogues in Cerebroside Sulfate Solution, 302
Wyche, Angela A. See LeDuc, Sprecher, Sankarappe, and Needle-
man, 242
Y
Yagi, H. See Nordqvist, Thakker, Vyas, Levin, Ryan, Thomas, Con.
ney, and Jerina, 168
Yamamura, Henry I. See Ehlert and Roeske, 367
Yamazaki, Mitsuo, Ohuchi, Kazuo, Sasaki, Masaaki, and Sakai,
Kiyoshi. Inhibition of 15-Hydroxyprostaglandin Dehydrogenase
by 9,1 1-Deoxyprostaglandins in Vitro and in Vivo, 456
Yang, Jen Tsi. See Wu, Lee, Ling, Chang, and Loh, 302
Yoda, Atsunobu, and Yoda, Shizuko. The Interation of Ouabagenin
and (Na� + Ki-ATPase in the Presence of Na�, Mg2�, and ATP,
62
Yoda, Shizuko. See Yoda, 62
Young, J. M. See Hill, 379
Z
Zaharko, Daniel S. See Ramonas, Erickson, Klesse, and Kohn, 331
Zahniser, Nancy R., Heidenreich, Kim A., and Molinoff, Perry B.
Binding of [:�H]Amino67dihythoxy4234tetrahydronaphthal
ene to Rat Striatal Membranes: Effects of Purine Nucleotides and
Ultraviolet Irradition, 372
Zelt, David T. See Cole and Marks, 477
Ziegler, D. M. See Duffel and Graham, 134
NOTICE
INSTRUCTIONS TO AUTHORS
Organization and style ofmanuscripts. The policy of the Journal
is to allow authors maximum freedom in organizing and presenting
Molecular Pharmacology will publish the results of investigations that shed significant light on drug action
or selective toxicity at the molecular level. The term “drug” is defined broadly to include chemical agents that
selectively modify biological function.
Suitable papers are those which describe applications of the methods of biochemistry, biophysics, genetics,
and molecular biology to problems in pharmacology or toxicology. Also suitable are reports of fundamental
investigations which, although not concerned directly with drugs, nevertheless provide an immediate basis for
further study of the molecular mechanism of drug action. Observations of phenomena that shed no light upon
underlying molecular interactions are not regarded as appropriate for publication.
Specific areas of interest include: stereochemical, electronic, and other parameters of drug architecture;
conformational analysis of receptors and their function; drug-enzyme and other interactions between drugs and
macromolecules; drug effects upon gene replication and transcription and on protein synthesis; mechanism of
action of antibiotics and other growth-inhibitory drugs; induction by drugs of changes in macromolecular
structure or allosteric transitions; drug-induced alterations in metabolic pathways; effects of hormones and
other drugs on cellular regulatory mechanisms; chemical mutagenesis, carcinogenesis, and teratogenesis;
pharmacogenetics, idiosyncrasies, and drug allergies; selective toxicity in a single organism or in different species;
drug actions on properties and functions of membranes; mechanisms of drug metabolism; distribution and
transport of drug molecules between biological compartments.
“Short Communications” will be considered for rapid publication if their subject matter lies within the scope
of the Journal, if they are concise, and if they are considered to be of sufficiently immediate importance to the
work of other investigators to justify accelerated publication. They may contain experimental observations,
theoretical material, or significant comment upon published investigations.
Page charges. Authors will be billed at the rate of $30.00 per
page after the paper has been published. It is expected that the page
charge will be paid if funds are available for that purpose from the
author’s institution or from the sponsor of this research. Payment
of the charge is not a condition for publication. Neither the editors
nor the reviewers will have knowledge as to who has paid the
charge, and this payment always will be considered entirely volun-
tary.
Submission ofmanuscript. Manuscripts are published in English
only and should be sent to the Editor, Dr. Norman Kirshner,
Department ofPharmacology, Duke University Medical Cen-
ter, Durham, North Carolina 27710, U.S.A. Manuscripts should
be typewritten double spaced with ample margins on one side of the
paper, 8#{189}x 1 1 inches (ca. 215 x 280 mm). Submit three complete
copies of the manuscript and three copies of each figure, plus one
original drawing or photograph of each figure. All pages should be
numbered consecutively beginning with the title page. Limit your
reference listings to the minimal number required to adequately
document the manuscript. In most instances 30 references or fewer
should suffice.
It is understood that the manuscripts and the results they contain
will not have been published previously and are not being submitted
elsewhere. Manuscripts are accepted for review with the under-
standing that all persons listed as authors have given their approval
for the submission of the paper; further, that any person cited as a
source of personal communications has approved such citation.
Written authorization may be required at the Editor’s discretion.
Articles and any other material published in Molecular Pharma-
cology represent the opinions of the author(s) and should not be
construed to reflect the opinions of the Editor(s) and the Publisher.
If and when a manuscript is published, it will become the sole
property of the Journal.
Authors submitting a manuscript do so on the understanding that
if it is accepted for publication, copyright in the article, including
the right to reproduce the article in all forms and media, shall be
assigned exclusively to the Society for Pharmacology and Experi-
mental Therapeutics. No reasonable request by the author for
permission to reproduce any of his or her contributions to the
journal will be refused.
their material, and in expressing their ideas, provided only that
clarity and conciseness are achieved.
Certain conventions must be observed. Chemical and mathemat-
ical formulas and abbreviations should follow the Instructions to
Authors oft/se Journal ofBiological Chemistry (Vol. 255, pp. 1-11,
January 10, 1980). Drugs must be referred to by their generic or
chemical names throughout the text, but may be identified by trade
name in parentheses or a footnote. The systematic name and
number given by the Commission on Enzymes of the International
Union of Biochemistry should be included for each enzyme of
importance in a paper, at the point in the Summary or Introduction
where the enzyme is first mentioned. The use of abbreviations
should be minimized and abbreviations avoided in the Summary.
All essential abbreviations should be defined in a single footnote
when first introduced. Abbreviations of journal names should con-
form to the style of Biological Abstracts. References to papers that
have been accepted for publication, but have not appeared, should
be cited like other references with the abbreviated name of the
journal followed by the words “in press.” Copies of such papers
should be sent whenever the findings described in them have a
direct bearing on the paper being submitted for publication. “Per-
sonal Communications” and “Unpublished Observations” should be
cited in footnotes to the text and should not be included in the
reference list.
A manuscript should include the following, in the order listed: (1)
Title. Numbered footnotes to the title should be avoided; acknowl-
edgment of financial support should be given in an unnumbered
footnote to the title. (2) Names of authors, their laboratory and
institution. (3) A running title, not exceeding 60 characters and
spaces. (4) Summary preceded by authors’ names and title of article.
For example:
SUMMARY
DAIRMAN, W., AND S. UDENFRIEND. Studies on the mechanismof the L-3,4-dihydroxyphenylalanine-induced decrease in tyrosine
hydroxylase activity. Mol. Pharmacol. 8:293-299 (1972).
(5) Text. Footnotes should be referred to by superscript numbers
and references by numbers in parentheses. (6) References, num-
bered according to order of citation in the text, including title and
complete pagination. Examples: 1. Goren, J. H., L. G. Bauce, and
W. Vale. Forces and structural limitations of binding of thyrotropin-
releasing receptor: the pyroglutamic acid moiety. Mol. Pharmacol.13:606-614 (1977). 2. Sandier, M. Variations in monoamine oxidase
activity in some human disease states, in Monoamine Oxidase andIts Inhibition. Ciba Foundation Symposium 39. Elsevier, Amster-
dam, 327-340 (1976) (7). Footnotes, numbered according to order of
appearance in the text. (8) Tables. (9) Figures. (10) Legends to
figures. (1 1) Name and address of person to receive galley proof.
Tables. These should be numbered with arabic numerals and
designed to fit the single-column width of the full-page width. Every
table should have an explanatory title and sufficient experimental
detail in a paragraph following the title to be intelligible without
references to the text (unless the procedure is given in the Methods
section, or under another table or figure). Footnotes to tables should
appear beneath the tables themselves and should be designated by
lower-case italic superscript letters, a, b, c, etc.
Figures. These should be numbered with arabic numerals. Each
of the three manuscript copies should contain all the figures, but
only the orignal set need be of quality suitable for reproduction.
These should be unmounted glossy photographs (or original India-
ink drawings). Usually figures will be reduced to one column width
(85 mm) and all numbers after such reduction should be at least 1.5
mm high. The figures must be ready, in all respects, for direct
reproduction: no lettering or other art work will be done by the
publisher. If symbols are not explained on the face of the figure,
only standard characters, of which the printer has type, may be
used (x, 0, #{149},0, R, E�, A, C). The back of each photograph should
bear its number, and the legend TOP at the appropriate edge. The
list of legends for the figures should give captions and sufficient
experimental detail, as required for tables.
Galley proof. The cost of all changes on galley proof, other than
printer’s errors, will be charged to authors. The Editors are very
much interested in having accepted contributions appear in the
earliest possible issue of the Journal, and therefore request that
galley proof be returned within 24 hours after its receipt. In excep-
tional cases, a “Note added in proof” may be attached and will be
published if the Editor approves.
Reprints andpage charges. An order form for reprints as well as
information on the estimation of page charges will be mailed with
galley proof. Please direct questions on reprints, page charges, or
other business matters to Dr. Houston Baker, Executive Officer,
American Society for Pharmacology and Experimental Therapeu-
tics, 9650 Rockville Pike, Bethesda, Md. 20014. Telephone (301)530-
7060.
MOLECULAR PHARMACOLOGY
An International Journal
VOLUME 19, 1981
EDITOR: NORMAN KIRSHNER
ASSOCIATE EDITOR: T. A. SLOTKIN
EDITORIAL AND ADVISORY BOARD
EARL BARIL HERBERT D. LANDAHL
R. B. BARLOW ROBERT J. LEFKOWITZ
L. L. BENNETT, JR. ANTHONY Y. H. Lu
N. J. M. BIRDSALL KARL MAGLEBY
JOEL BOCKAERT GILBERT J. MANNERING
BRUCE BRECKENRIDGE RONALD M. MCELHANEY
THEODORE M. BRODY KEITH W. MILLER
ERNEST BUEDING PERRY B. MOLINOFF
A. S. V. BURGEN DANIEL W. NEBERT
WILLIAM CATTERALL CHARLES A. NICHOL
COLLIN F. CHIGNELL JOHN P. PERKINS
RONALD CHUANG RICHARD M. PHILPOT
DoMINICK L. CINTI BERNARD PULLMAN
P. MICHAEL CONN K. V. RAJAGOPALAN
BRIAN Cox H. P. RANG
JOHN W. DALY ELLIOTT RICHELSON
JAMES N. DAVIS MARTIN RODBELL
GEORGE I. DRUMMOND GERALD ROSEN
MOHYEE E. ELDEFRAWI JOHN B. SCHENKMAN
ROBERT F. FURCHGOTF ARNOLD SCHWARTZ
ALFRED G. GILMAN DAVID SILVERMAN
ROBERT I. GLAZER IAN C. P. SMITH
DAVID V. G0DIN SOLOMON H. SNYDER
AVRAM GOLDSTEIN SNORRI S. THORGEIRSSON
H. JOSEPH GOREN JAMES R. TRUDELL
CHARLES HEIDELBERGER PAUL 0. P. Ts’o
GEORGE H. HITCHINGS DAVID C. U’PRICHARD
DONALD JERINA WYLIE W. VALE
ARTHUR KARLIN ELLIOT S. VESELL
JOYCE J. KAUFMAN 0. H. VIVEROS
SEYMOUR KAUFMAN MICHAEL J. WARING
LEMONT B. KIER HAREL WEINSTEIN
ERNEST KUN
CONTENTS OF VOLUME 19
NUMBER 1, JANUARY 1981
ALLEN P. MINTON. The Bivalent Ligand Hypothesis: A Quantitative Model for HormoneAction 1
GREGORY J. WASTEK, J. RAPHAEL LOPEZ, AND ELLIOTT RICHELSON. Demonstration of aMuscarinic Receptor-Medicated Cyclic GMP-Dependent Hyperpolarization of the Mem-brane Potential of Mouse Neuroblastoma Cells Using [3H]Tetraphenylosphonium 15
ELINOR H. CANTOR, LOUISE H. GREENBERG, AND BENJAMIN WEISS. Effect of Long-TermChanges in Sympathetic Nervous Activity on the Beta-Adrenergic Receptor-AdenylateCyclase Complex of Rat Pineal Gland 21
M. J. W. BRENNAN, R. C. CANTRILL, M. OLDFIELD, AND P. KROGSGAARD-LARSEN. Inhibitionof -y-Aminobutyric Acid Release by -y-Aminobutyric Acid Agonist Drugs: Pharmacology ofthe -y-Aminobutyric Acid Receptor 27
RONALD P. RUBIN, LYNN E. SINK, AND RICHARD J. FREER. On the Relationship betweenFormylmethionyl-Leucyl-Phenylalanine Stimulation of Arachidonyl PhosphatidylinositolTurnover and Lysosomal Enzyme Secretion by Rabbit Neutrophils 31
ROGER BARBER AND REGINALD W. BUTCHER. The Quantitative Relationship between Intra-cellular Concentration and Egress of Cyclic AMP from Cultured Cells 38
B. H. MooN, V. S. PAl, AND E. W. MAYNERT. Ring Stacking in Solutions of Norepmephrineand the 4:1 Norepinephrine . ATP Complex 44
MICHAEL J. PRINGLE, KENNETH B. BROWN, AND KEITH W. MILLER. Can the Lipid Theoriesof Anesthesia Account for the Cutoff in Anesthetic Potency in Homologous Series ofAlcohols? 49
S. ALEXANDER STERN AND SHII-PYNG SHIAH. Solubiity of Inhalation Anesthetics in VariousMedia: A New Correlation 56
ATSUNOBU YODA AND SHIZUKO YODA. The Interaction of Ouabagenin and (Na� + K�)-ATPase in the Presence of Na�, Mg2�, and ATP 62
PETER HONERJAGER, MELCHIOR REITER, AND PETER F. BAKER. Effect of the CardioactiveDrug AR-L 57 on Free Intracellular Calcium and Ouabain-Insensitive Ion Fluxes in theSquid Giant Axon 68
MICHAEL M. TAMKUN AND WILLIAM A. CATTERALL. Ion Flux Studies of Voltage-SensitiveSodium Channels in Synaptic Nerve-Ending Particles 78
D. S. ROSENBLATT, V. M. WHITEHEAD, M.-J. VUCHICH, A. POTTIER, N. VERA MATIASZUK,
AND DENISE BEAULIEU. Inhibition of Methotrexate Polyglutamate Accumulation inCultured Human Cells 87
DAVID T. VISTICA AND BARBARA P. SCHUETTE. Carrier Mechanism and Specificity Account-ing for the Increase in Intracellular Melphalan by the Basic Amino Acids 92
JAN M. WOYNAROWSKI AND JERZY KONOPA. Inhibition of DNA Biosynthesis in HeLa Cellsby Cytotoxic and Antitumor Sesquiterpene Lactones 97
BARBARA KUHN, ANGEL ALONSO, AND PETER C. HEINRICH. The Effect of D-Galactosamineand Actinomycin D on Polysomes and Messenger RNA Levels in Rat Liver 103
MICHAEL R. SALOMON AND HENRY R. BOURNE. Novel 549 Lymphoma Variants withAberrant Cyclic AMP Metabolism 109
ROBERT I. GLAZER AND KATHLEEN D. HARTMAN. Analysis of the Effect of 5-Fluorouradil onthe Synthesis and Translation of Polysomal Poly(A)RNA from Ehrlich Ascites Cells . . . 117
ERIK DE CLERCQ, HUBERTINE HEREMANS, JOHAN DESCAMPS, GABRIEL VERHELST, MARC DE
LEY, AND ALFONS BILLIAU. Effects of E-5-(2-Bromovinyl)-2’-Deoxyuridine and OtherSelective Anti-Herpes Compounds on the Induction of Retrovirus Particles in Mouse 122BALB/3T3 Cells
GUNTER FIRNAU, SUDESH SooD, RICHARD PANTEL, AND STEPHEN GARNETT. Phenol loni-zation in Dopa Determines the Site of Methylation by Catechol-O-Methyltransferase . . . 130
MICHAEL W. DUFFEL, J. MICHAEL GRAHAM, AND D. M. ZIEGLER. Changes in DimethylanilineN-Oxidase Activity of Mouse Liver and Kidney Induced by Steroid Sex Hormones 134
SIDNEY D. NELSON, ANTHONY J. FORTE, YASHESH VAISHNAV, JERRY R. MITCHELL, JAMES R.GILLETTE, AND JACK A. HINSON. The Formation of Arylating and Alkylating Metabo-lites of Phenacetin in Hamsters and Hamster Liver Microsomes 140
PATRICIA L. ASHLEY AND BRENDA WALKER GRIFFIN. Involvement of Radical Species in theOxidation of Aminopyrine and 4-Aminoantipyrine by Cumene Hydroperoxide in RatLiver Microsomes 146
E. M. GOZUKARA, G. BELVEDERE, R. C. ROBINSON, J. DEUTSCH, M. J. CooN, F. P. GUENGER-
ICH, AND H. V. GELBOIN. The Effect of Epoxide Hydratase on Benzo[a]-pyrene DiolEpoxide Hydrolysis and Binding to DNA and Mixed-Function Oxidase Proteins 153
DONALD E. NERLAND, MICHAEL M. IBA, AND GILBERT J. MANNERING. Use of Linoleic AcidHydroperoxide in the Determination of Absolute Spectra of Membrane-Bound Cyto-chrome P-450 162
M. NORDQVIST, D. R. THAKKER, K. P. VYAS, H. YAGI, W. LEVIN, D. E. RYAN, P. E. THOMAS,A. H. CONNEY, AND D. M. JERINA. Metabolism of Chrysene and Phenanthrene to Bay-Region Diol Epoxides by Rat Liver Enzymes 168
SHORT COMMUNICATIONS
SANFORD J. SHArFIL, MARGARET MCDONOUGH, JUDY TURNBULL, AND PAUL A.INSEL. Characterization of Alpha-Adrenergic Receptors in Human Platelets Using[3HjClonidine 179
SU-SHU PAN, LESLIE PEDERSEN, AND NICHOLAS R. BACHUR. Comparative FlavoproteinCatalysis of Anthracycine Antibiotic: Reductive Cleavage and Oxygen Consumption . . . 184
NUMBER 2, MARCH 1981
JOHN A. MOYER, LOUISE H. GREENBERG, ALAN FRAZER, AND BENJAMIN
WEISS. Subsensitivity of the Beta-Adrenergic Receptor-Linked Adenylate Cyclase Sys-tern of Rat Pineal Gland following Repeated Treatment with Desmethylimipramineand Nialamide 187
K. DICKINSON, A. RICHARDSON, AND S. R. NAHORSKI. Homogeneity of Beta 2-Adrenoceptorson Rat Erythrocytes and Reticulocytes: A Comparison with Heterogenous RatLung Beta-Adrenoceptors 194
ERNST BURGISSER, ARTHUR A. HANCOCK, ROBERT J. LEFKOWITZ, AND ANDRE DE
LEAN. Anomalous Equilibrium Binding Properties of High-Affinity Racemic Radioli-gands 205
RICHARD W. OLSEN, MARK 0. BERGMAN, PAUL C. VAN NESS, SARAH C. LUMMIS, ANDREW E.WATKINS, CHRISTIAN NAPIAS, AND DONALD V. GREENLEE. -y-Aminobutyric Acid Recep-tor Binding in Mammalian Brain: Heterogeneity of Binding Sites 217
THOMAS TR05T AND ULRICH SCHWABE. Adenosine Receptors in Fat Cells: Identification by(-)-N6-[’3H]Phenylisopropyladenosine Binding 228
JEFFRY L. VAUGHT, TAKAFUMI KITANO, AND A. E. TAKEMORI. Interactions of LeucineEnkephalin and Narcotics with Opioid Receptors 236
LOUISE E. LEDUC, ANGELA A. WYCHE, HOWARD SPRECHER, S. K. SANKARAPPE, AND PHILIP
NEEDLEMAN. Analogues ofArachidonic Acid Used To Evaluate Structural Determinantsof Prostaglandin Receptor and Enzyme Specificities 242
RICHARD J. SCHIMMEL, KATHRYN K. MCMAHON, AND ROSALIND SERb. Interactions betweenAlpha-Adrenergic Agents, Prostaglandin E1, Nicotinic Acid, and Adenosine in Regulationof Lipolysis in Hamster Epididymal Adipocytes 248
M. GNEGY AND G. TREISMANN. Effect of Calmodulin on Dopamine-Sensitive AdenylateCyclase Activity in Rat Striatal Membranes 256
WALTER C. PROZIALECK, MAURO CIMIN0, AND BENJAMIN WEISS. Photoaffinity Labeling of
Calmodulin by Phenothiazine Antipsychotics 264
MICHAEL J. BANNON, RICHARD L. MICHAUD, AND ROBERT H. ROTH. Mesocortical DopamineNeurons: Lack of Autoreceptors Modulating Dopamine Synthesis 270
RICHARD J. MILNE AND JOHN H. BYRNE. Effects of Hexamethonium and Decamethoniumon End-Plate Current Parameters 276
ESAM EL-FAKAHANY AND ELLIOTT RICHELSON. Effects of Lanthanides on Muscarinic Ace-tyicholine Receptor Function 282
MATS HANSON. Effects of Mitosis Inhibitors on Respiration and Fast Axonal Transport inFrog Sciatic Nerves 291
A. G. APPU RAO AND JOHN R. CANN. A Comparative Study of the Interaction of Chiorpro-mazine, Tnfiuoperazine, and Promethazine with Mouse Brain Tubulin 295
CHUEN-SHANG, C. WU, NANCY M. LEE, NICHOLAS LING, JAW KANG CHANG, HORACE H. LOH,AND JEN TsI YANG. Conformation of /3-Endorphin Analogues in Cerebroside Sul-fate Solution . 302
JANICE R. SUFRIN, DEBORAH A. DUNN, AND GARLAND R. MARSHALL. Steric Mapping of theL-Methionine Binding Site of ATP:L-Methionine S-Adenosyltransferase 307
STANLEY FRIEDMAN. The Inhibition of DNA(Cytosine-5)Methylases by 5-Azacytidine: TheEffect of Azacytosine-Containing DNA 314
E. DE CLERCQ, J. BALZARINI, P. F. TORRENCE, M. P. MERTES, C. L. SCHMIDT, D. SHUGAR P.J. BARR, A. S. JONES, G. VERHELST, AND R. T. WALKER. Thymidylate Synthetase asTarget Enzyme for the Inhibitory Activity of 5-Substituted 2’-Deoxyuridines on MouseLeukemia L 1210 Cell Growth 321
LORI M. RAMONAS, LEONARD C. ERICKSON, WOLFGANG KLESSE, KURT W. KOHN, AND DANIEL
S. ZAHARKO. Differential Cytotoxicity and DNA Cross-Linking Produced by Polymericand Monomeric Activated Analogues of Cyclophosphamide in Mouse L1210 Leu-kemia Cells . . 331
PETER J. WIRTH AND SNORRI S. THORGEIRSSON. Mechanism of N-Hydroxy-2-Acetylamino-
fluorene Mutagenicity in the Salmonella Test System: Role of N-O Acyltransferase andSulfotransferase from Rat Liver . . . . 337
SHORT COMMUNICATIONS
WILLIAM A. CATTERALL AND MARTIN RISK. Toxin T4 . from Ptychodiscus brevis (FormerlyGymnodinium breve) Enhances Activation of �Voltage-Sensitive Sodium Channelsby Veratridine 345
CHRIS LINGLE, JUDITH S. EISEN, AND EVE MARDER. Block of Glutamatergic ExcitatorySynaptic Channels by Chlorisondamine 349
ERRATUM 354
NUMBER 3, MAY 1981
P. Y. LAW, T. J. OSTWALD, E. L. WAY, AND H. H. LOH. Interaction of Diazosulfanilic Acidand the Opiate Receptor: Inhibition of Specific Binding to Synaptic Membranes andLabeling of a Membrane Lipid Sterospecifically Protected by Opioids . . 355
FREDERICK J. EHLERT, WILLIAM R. ROESKE, AND HENRY I. YAMAMURA. MathematicalAnalysis of the Kinetics of Competitive Inhibition in Neurotransmitter Receptor BindingAssays 367
NANCY R. ZAHNISER, KIM A. HEIDENREICH, AND PERRY B. MOLINOFF. Binding of [3H]-Amino-6,7-dihydroxy- 1,2,3,4-tetrahydronaphthalene to Stnatal Membranes: Effects of Pu-rine Nucleotides and Ultraviolet Irradiation . . 372
S. J. HILL AND J. M. YOUNG. Characterization of [3HjMepyramine Binding to the Longitu-dinal Muscle of Guinea Pig Small Intestine 379
MICHAEL R. KILBOURN, A. J. ARDUENGO, JooN T. PARK, AND JOHN A. KATZENELLENBO-
GEN. Conformational Analysis of Nonsteroidal Estrogens: The Effect of ConformerPopulations on the Binding Affinity of meso- and dl-Hexestrol to the Estrogen Receptor 388
JAN MARIAN, RALPH L. COOPER, AND P. MICHAEL CONN. Regulation of the Rat PituitaryGonadotropin-Releasing Hormone Receptor . . 399
HARVEY R. KASLOW, DAVID Cox, VINCENT E. GROPPI, AND HENRY R. BOURNE. An Mr
52,000 Peptide Can Mediate Effects of Cholera Toxin on Adenylate Cyclase in In-tact Cells . 406
E. X. ALBUQUERQUE, J. E. WARNICK, M. A. MALEQUE, F. C. KAUFFMAN, R. TAMBURINI, Y.NIMIT, AND J. W. DALY. The Pharmacology of Pumiiotoxin-B. I. Interaction withCalcium Sites in the Reticulum of Skeletal Muscle 411
J. H. CHIN AND D. B. GOLDSTEIN. Membrane-Disordering Action of Ethanol: Variation withMembrane Cholesterol Content and Depth of the Spin Label Probe . . . . . . 425
H. J. GALLA AND J. R. TRUDELL. Perturbation of Peptide-Induced Lateral Phase Separationsin Phosphatidic Acid Bilayers by the Inhalation Anesthetic Methoxyfiurane . . . 432
DANIELE CU5I AND RICARDO GARAY. The Effect of Tieniic Acid on Na� and K� SodiumTransport in Human Red Cells 438
RONALD P. FRIGON, DANIEL T. O’CONNOR, AND GAIL L. LEVINE. Human Dopamine-f3-Hydroxylase: Comparison of the Enzyme from Plasma, Adrenal Medulla, and Pheochro-rnocytoma by Radioimmunoassay 444
SEBASTIAN CERDAN, MARIA CASCALES, AND ANGEL SANTOS-RUIZ. Effect of Thioacetamideon the Pentose Phosphate Pathway and Other NADP-Linked Enzymes of Rat LiverCytosol: Chronology of the Perturbations and Metabolic Significance 451
MITSUO YAMAZAKI, KAZUO OHUCHI, MASAAKI SASAKI, AND KIYOSHI SAKAI. Inhibition of 15-Hydroxyprostaglandin Dehydrogenase by 9,11-Deoxyprostaglandins in Vitro and in Vivo 456
JARLE AARBAKKE AND PER M. UELAND. Interaction of S-Adenosylhomocysteine with Iso-lated Rat Hepatocytes 463
DONALD E. MACFARLANE. The Effects of Methyl Mercury on Platelets: Induction of Aggre-gation and Release via Activation of the Prostaglandin Synthesis Pathway 470
SUSAN P. C. COLE, DAVID T. ZELT, AND GERALD S. MARKS. Comparison of the Effects ofGriseofulvin and 3,5-Diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on Ferroche-latase Activity in Chick Embryo Liver 477
KEVIN J. SCANLON, ARLENE R. CASHMORE, BARBARA A. MoRosoN, ROBERT N. DREYER, AND
JOSEPH R. BERTINO. Inhibition ofSerine Metabolism by Tetrahydrohomofolate in L1210Mouse Leukemia Cells 481
MICHAEL R. HAMRELL, JOHN LASZLO, AND W. DAVID SEDWICK. Transient Induction ofPhenotypic Resistance in Human Lymphoblastoid Cells following Sequential Use ofTwo Antifolates 491
C. PAUL SPEARS. Nucleophiic Selectivity Ratios of Model and Clinical Alkylating Agents by4-(4’-Nitrobenzyl)pyridine Competition 496
SHORT COMMUNICATIONS
JOHN M. WHITELEY, ZENIA NIMEC, AND JOHN GALIVAN. Treatment of Reuber H35 Hepa-toma CbIIS with Carrier-Bound Methotrexate 505
ERNST BURGHISSER, ROBERT J. LEFKOWITZ, AND ANDRE DELEAN. Alternative Explanationfor the Apparent “Two-Step” Binding Kinetics of High-Affinity Racemic AntagonistRadioligands 509
SUNGCHUL Ji, JOHN J. LEMASTERS, AND RONALD G. THURMAN. A Fluorometric Method ToMeasure Sublobular Rates of Mixed-Function Oxidation in the Hemoglobin-Free PerfusedRat Liver 513
NORMAN CAMERMAN AND ARTHUR CAMERMAN. On the Stereochemistry of DopaminergicErgoline Derivatives 517
SUE A. WARTELL, ROSE CHRISTOPHERSON, CLYDE A. WATKINS, AND D. EUGENE
RANNELS. Inhibition of Synthdsis of Lung Proteins by Halothane 520
ROBERT M. LEVIN, RICHARD JACOBY, AND ALAN J. WEIN. Effect of Adenosine Triphosphateon Contractility and Adenosine Triphosphatase Activity of the Rabbit Urinary Bladder 525
AUTHOR INDEX FOR VOLUME 19 529The Subject Index for Volume 19 will appear in the November 1981 issue as part of a
cumulative index for the year 1981.